Cleared Traditional

K133779 - CP RELIEF WAND

K133779 is an FDA 510(k) clearance for CP RELIEF WAND, manufactured by Mid-America Medical Innovations, LLC. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 169-day FDA review.

K133779 · Mid-America Medical Innovations, LLC · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
May 2014
Decision
169d
Days
Class 2
Risk

K133779 is an FDA 510(k) clearance for the CP RELIEF WAND. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Mid-America Medical Innovations, LLC (Jefferson City, US). The FDA issued a Cleared decision on May 30, 2014 after a review of 169 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K133779

510(k) Number K133779 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 2013
Decision Date May 30, 2014
Days to Decision 169 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d slower than avg
Panel avg: 149d · This submission: 169d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 381
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K133779.
Synapse Transcutaneous Electrical Stimulation Device
K143198 · Synapse Electroceutical Limited · May 2015
Scrambler Therapy MC-5 A Device
K142666 · Delta International Services & Logistics S.R.L · May 2015
SCENAR (SCELAP, ENISAR, IPENS) CUTANEOUS ELECTRODE FAMILY
K131513 · Ritm Okb Zao · Jul 2014
Best-AV2 Pro-Sport(tm)
K123099 · Avazzia, Inc. · May 2014
BODIHEALTH SYSTEM
K131675 · Eprt Technologies, Inc. · Mar 2014
JIAJIAN POINTOSELECT DIGITAL
K123958 · Wuxi Jiajian Medical Instrument Co., Ltd. · Oct 2013